Issues in modern drug packaging MCQs With Answer

Issues in modern drug packaging MCQs With Answer

by

Introduction

This quiz compilation covers key issues in modern drug packaging, designed for M.Pharm students focusing on Product Development and Technology Transfer. It highlights technical, regulatory and material-science aspects that influence package selection and performance, such as container-closure integrity, extractables and leachables, barrier properties, cold chain management, and compatibility with biologics. Questions emphasize practical implications for stability, patient safety, and process transfer, and introduce advanced testing methods and regulatory expectations. Use these MCQs to test and deepen your understanding of how packaging choices affect product quality, manufacturability and regulatory compliance during drug development and technology transfer.

Q1. Which of the following best describes the primary purpose of container-closure integrity (CCI) testing in pharmaceutical packaging?

  • To evaluate aesthetic appearance of the packaging
  • To confirm microbial and physical protection of the product by ensuring absence of leaks
  • To quantify extractables and leachables from packaging materials
  • To determine mechanical strength during transport

Correct Answer: To confirm microbial and physical protection of the product by ensuring absence of leaks

Q2. Which CCI method is most suitable for non-destructive testing of parenteral syringe systems at production scale?

  • Dye ingress testing
  • Helium leak detection
  • Vacuum decay testing
  • Microbial challenge test

Correct Answer: Vacuum decay testing

Q3. In extractables and leachables (E/L) programs, which step is critical to identify potential toxicological risks to patients?

  • Measuring tensile strength of packaging film
  • Performing identification and quantitation of leachables and comparing to safety thresholds
  • Conducting FTIR to check polymer crystallinity
  • Evaluating ink adhesion on secondary packaging

Correct Answer: Performing identification and quantitation of leachables and comparing to safety thresholds

Q4. Which regulatory guidance specifically addresses assessment of extractables and leachables for parenteral drugs?

  • ICH Q6A
  • ICH Q1A(R2)
  • USP <1663> and <1664>
  • ICH Q8(R2)

Correct Answer: USP <1663> and <1664>

Q5. Which packaging material is most associated with the risk of delamination in glass vials intended for parenterals?

  • Type I borosilicate glass
  • Type II treated glass
  • Type III soda-lime glass
  • Flint glass

Correct Answer: Type II treated glass

Q6. For biologic protein formulations, which packaging-related phenomenon can cause particle formation and reduce potency?

  • Oxygen scavenger activity
  • Adsorption to container surfaces and silicone oil-induced aggregation
  • Glass annealing
  • Excess desiccant use

Correct Answer: Adsorption to container surfaces and silicone oil-induced aggregation

Q7. Which approach is most appropriate to control moisture-sensitive oral solid dosage forms during packaging and storage?

  • Use of clear flint glass primary containers
  • Packaging with desiccants, moisture barrier films and tight CCI
  • Reducing tablet hardness to allow moisture escape
  • Using high-oxygen headspace in blisters

Correct Answer: Packaging with desiccants, moisture barrier films and tight CCI

Q8. Modified atmosphere packaging for oral solids typically replaces headspace with which gas to improve stability?

  • Nitrogen to reduce oxidative degradation
  • Carbon dioxide to increase moisture
  • Oxygen to preserve color
  • Helium to increase solubility

Correct Answer: Nitrogen to reduce oxidative degradation

Q9. Which packaging attribute is most critical for photosensitive drug substances?

  • High oxygen transmission rate
  • Light attenuation or UV-blocking barrier
  • Permeability to water vapor
  • Printed artwork quality

Correct Answer: Light attenuation or UV-blocking barrier

Q10. Which test is a regulatory expectation for sterile product packaging when performing technology transfer to a new manufacturing site?

  • Headspace gas chromatography for residual solvents only
  • Container closure integrity testing and transfer validation showing equivalent CCI
  • Only visual inspection of labels
  • Mechanical drop test of retail cartons

Correct Answer: Container closure integrity testing and transfer validation showing equivalent CCI

Q11. What is the primary reason to perform migration studies for packaging inks and adhesives?

  • To measure print sharpness on the label
  • To determine potential transfer of ink/adhesive components into the drug product and assess safety
  • To optimize drying time during printing
  • To ensure barcode readability

Correct Answer: To determine potential transfer of ink/adhesive components into the drug product and assess safety

Q12. Which phenomenon is most likely to compromise sterility of a prefilled syringe during shipping?

  • Absence of primary labeling
  • Formation of micro-channels due to mechanical stress leading to loss of CCI
  • Use of colorless glass
  • Low humidity in the transport environment

Correct Answer: Formation of micro-channels due to mechanical stress leading to loss of CCI

Q13. Which analytical technique is commonly used to identify unknown organic leachables at trace levels?

  • ICP-MS
  • NIR spectroscopy only
  • LC-MS/TOF or GC-MS
  • Thermogravimetric analysis

Correct Answer: LC-MS/TOF or GC-MS

Q14. Which packaging consideration is most relevant for temperature-sensitive biologics during global distribution?

  • Choice of cap color
  • Cold chain integrity, validated temperature-controlled packaging and excursion management
  • Use of blister packs instead of vials
  • Use of desiccants to control oxygen

Correct Answer: Cold chain integrity, validated temperature-controlled packaging and excursion management

Q15. Which of the following is a key advantage of using cyclic olefin polymer (COP) or cyclic olefin copolymer (COC) for parenteral containers?

  • High oxygen permeability compared to PVC
  • Excellent optical clarity, low extractables and good moisture barrier
  • High leachable silicone content
  • Intrinsic antimicrobial activity

Correct Answer: Excellent optical clarity, low extractables and good moisture barrier

Q16. Sustainable packaging goals in pharmaceuticals can conflict with product protection. Which example best illustrates this trade-off?

  • Replacing heavy glass with lightweight polymers that may increase oxygen or moisture ingress risk
  • Printing plain text instead of color labels
  • Using recycled cardboard for shipping boxes only
  • Reducing font size on leaflets

Correct Answer: Replacing heavy glass with lightweight polymers that may increase oxygen or moisture ingress risk

Q17. Which test would you select to detect very small leaks (<10^-6 mbar·L/s) in a vacuum-tight parenteral vial system during development?

  • Dye ingress (water immersion)
  • Helium mass spectrometry leak detection
  • Visual inspection under white light
  • Desiccant weight gain

Correct Answer: Helium mass spectrometry leak detection

Q18. For blister packaging of oral solids, which property of the film/foil laminate is most critical to maximize shelf-life of a moisture-sensitive drug?

  • Low puncture resistance
  • High water vapor transmission rate (WVTR)
  • Low water vapor transmission rate (WVTR) and strong seal integrity
  • Translucent appearance for marketing

Correct Answer: Low water vapor transmission rate (WVTR) and strong seal integrity

Q19. During technology transfer of a packaging line, which of the following is most important to ensure equivalent container quality at receiving site?

  • Only transferring artwork files
  • Comprehensive transfer of process parameters, equipment qualification, packaging material specs and acceptance criteria
  • Changing to locally available, unspecified materials to save cost
  • Reducing in-process inspection to speed up transfer

Correct Answer: Comprehensive transfer of process parameters, equipment qualification, packaging material specs and acceptance criteria

Q20. Which issue is specifically critical for prefilled glass syringes filled with biologic drugs and requires targeted risk assessment?

  • Color matching of secondary carton
  • Protein-silicone oil interactions, particle formation and potential immunogenicity
  • Excessive paper leaflet thickness
  • Increased oxygen in secondary packaging

Correct Answer: Protein-silicone oil interactions, particle formation and potential immunogenicity

Leave a Comment